Board of Directors
Sandra F. Rorem - Director, Board Chair
Sandra’s accomplished career spans over 35 years of executive leadership in all facets of healthcare delivery and health-related companies, including leading five start-up and early-stage ventures.
Her career and experience with healthcare delivery in large integrated systems began with the Fairview Health System in Minneapolis, Minnesota. During her 10 years with Fairview, she held increasingly responsible positions and in addition, was instrumental in establishing and growing a medical residency program through the Department of Family Practice and Community Health at the University of Minnesota. She left to assist the University of Washington Program in attaining the same growth experience at a time when demand for primary care physicians was increasing across the country.
Sandra joined the Providence Health System in 1978 and for 18 years served as a Hospital Administrator at Seattle’s Cherry Hill Campus, followed by five years as Chief Executive Officer for Medalia Healthcare -- a 350 physician group, formed by the merger of the Providence and Franciscan Health Systems primary care networks.
Following her tenure with the Providence Health System, Sandra shifted her focus to new ventures -- primarily start-up and early stage, health-related companies. Over the last 16 years she has led five. Sandra served as the CEO of ClearMedical, a medical manufacturing company; as CEO of Accium BioSciences, a company which provides services to the global pharmaceutical and life science industries using Accelerator Mass Spectrometry (AMS). She served as start-up consultant and board member for REM Medical, a provider of sleep centers across the country. She co-founded and co-owned CareGifting which provided support and care products for seriously ill or injured persons. After the sale of CareGifting she dedicated her time to setting up and leading Distinctive Solutions, LLC a consulting firm where she and her team were advisory to healthcare organizations focusing on business development, start-up programs and projects as well as interim executive management and leadership of on-going operations.
Sandra has served on numerous boards, including Flow International (NASDQ), The National Association of Corporate Directors (NACD) West Region, REM Medical, The British American Chamber of Commerce, Neighborhood House, Treeswing, and several others. She is a Board Certified member and Diplomat in the American College of Health Care Executives and a member of the American College of Medical Practice Administrators. She holds an MBA from the University Of Washington Foster School Of Business.
Christopher Ackerley - Director
Christopher is a co-founder and Managing Director of Ackerley Partners, LLC, a private investment company focused on the media and entertainment sectors. Prior to founding Ackerley Partners in 2002, Chris was the President of The Ackerley Group, Inc. (NYSE: AK) where he oversaw the daily operations of the national media and entertainment company. He served in a variety of roles for the company for more than 15 years, and was also a member of the company’s board of directors. Mr. Ackerley successfully led the merger of The Ackerley Group, Inc. with Clear Channel Communications, Inc. (NYSE: CCU) and led the negotiations and completion of The Ackerley Group’s sale of the Seattle SuperSonics and the Seattle Storm to The Basketball Club of Seattle led by Starbucks Chairman and CEO – Howard Schultz.
Chris began his career in the Capital Markets Group at Bank of America in London, England after college at the University of Arizona. He has and continues to serve on a number of corporate boards including Washington Trust Bank, Limeade, Inc., and Sparq.me.
Chris has been involved with many civic and community organizations including the Pacific Science Center, the Downtown Seattle Association and Lakeside School. He also serves as a Vice-President of their family foundation - The Ginger and Barry Ackerley Foundation. In 2001, Mr. Ackerley was recognized by the Puget Sound Business Journal as one of the region’s most influential “40 Under 40” business leaders and in 2004, he was the recipient of the inaugural Outstanding Alumni Board Member Award by Seattle Works for his many contributions to the Seattle community. In 2007, he was inducted into the Hall of Honor for the Beta Phi Chapter of The Sigma Chi Fraternity.
David C. Bradshaw - Director
David C. Bradshaw has nearly 30 years of experience in investment banking, mergers and acquisitions and the energy industry. Dave currently serves as a Senior Advisor at Moelis & Company, a leading global independent investment bank, based in Houston. Dave served as a Managing Director in the Investment Banking Division of Houston-based Tudor, Pickering, Holt & Company from 2013-2016. Previously, he was a partner of The Cherokee Group, Inc.—an energy industry consulting group—since the firm was founded in 2003 and from 2005-2013. He was an Advisory Director to the Investment Banking Division of UBS Investment Bank which followed a similar assignment with Deutsche Bank in the 2003-2005 time frame.
Dave was ranked among the top analysts on the All-America Research Team by Institutional Investor magazine in the period of 1989-2002. Mr. Bradshaw is a member of the New York Society of Security Analysts, the National Association of Petroleum Investment Analysts, Petroleum Exploration Society of New York, the International of Association of Energy Economists, Oil Analysts Group of New York and the Association for Investment Management and Research.
Previously, Dave served as a Managing Director and a senior equity analyst at Deutsche Bank in New York covering the Oils: Exploration & Production sector; a Vice President and the Exploration and Production analyst at Donaldson, Lufkin & Jenrette; a Managing Director and senior energy analyst at PaineWebber Incorporated in New York; and a Vice President covering the energy sector for Rauscher Pierce Refsnes in Dallas.
Dave graduated with a BS in Finance from Oklahoma State University and received an MS in Finance from Texas Tech University. He is a Chartered Financial Analyst. In 2001, Dave was inducted into the Spears School of Business Hall of Fame and in 2014, he was recognized among the Spears School Tributes: 100 For 100. Mr. Bradshaw is involved in the Manhattan Council of the Boy Scouts of America, the Gary Sinise Foundation and serves on the Board of Directors for the Houston Producers’ Forum.
Mona Lee Locke - Director
Mona Lee Locke is a seasoned communications and marketing executive with unique hands-on global experience in the political, public and private sectors. As a journalist, a diplomat, former First Lady of Washington State and an executive leader of high-profile organizations, Locke has been in the trenches and on both sides of the camera. She uses this informed perspective, as well as her natural inquisitiveness, to build relationships, mobilize stakeholders, create a common mission through comprehensive strategy, implement crisis management, develop clear vision and operational alignment, and tell the compelling story. Having lived in China and worked at the U.S. Embassy in Beijing, as well as with the Obama administration, she is an expert on U.S.-China relations, and knows the political and social landscape of both countries and how to navigate them successfully.
Most recently, Locke served as Senior Vice President of Communications and Marketing for Intellectual Ventures, a global company focused on invention. She was a part of the leadership team and was responsible for revitalizing the corporate brand and reputation while expanding the company’s international footprint through public relations, communications, marketing and external relations. Locke also has nearly two decades of not-for-profit experience as a founder, board chair and trustee in the fields of healthcare, business, education and the arts. She has served on board committees including governance, nominations, education, research and compliance. As former First Lady of Washington State, she co-chaired the Governor’s Commission on Early Learning. The Washington State Department of Early Learning was created six years later.
Locke takes pride in championing women’s issues, higher education, diversity and inclusion, believing that one can only achieve balance by bringing all voices to the table. This is evident through her work in Beijing with the Economic section of the State Department, where she led a series of Women CEO forums promoting partnerships and mentorship. She also served as Special Advisor to the EducationUSA program using social media, and traveling throughout China to promote student exchange in higher education. As Executive Director of the Puget Sound affiliate of Susan G. Komen, she increased diversity in the workplace by 50% and on the board by 25% within two years.
Locke graduated with a Masters of Science in Journalism from the Medill School at Northwestern University, and earned a Bachelor’s of Arts in English from the University of California, at Berkeley. She completed Harvard Business School’s Executive Education Program in Governing for Non-Profit Leadership. She is an Emmy-nominated, award-winning broadcast journalist who has received media and community service recognition, ranging from the Edward R. Murrow Regional Excellence Award, to the Champion of Youth Award, to the Helen S. Jackson Medal of Valor, awarded by U.S. Senator Patty Murray.
Sean D. Sullivan - Director
Sean D. Sullivan, BScPharm, MSc, PhD, is Professor of Pharmacy and Dean, School of Pharmacy. He holds a joint appointment as Professor of Health Services in the School of Public Health. He holds adjunct appointments in the School of Medicine, the Public Health Sciences Division at the Fred Hutchinson Cancer Research Center, and at Group Health Research Institute.
He completed training in pharmacy at Oregon State University in 1983, obtained a master’s degree at the University of Texas in 1986 and a PhD in health economics and policy at the University of California-Berkeley in 1991.
Dr. Sullivan has authored more than 350 journal articles, book chapters, task force reports and organizational and governmental publications. In many of these writings, he has assessed the evidence and applications of medical technology in relation to coverage and reimbursement decisions. His research interests include technology assessment, medical decision-making and economic evaluation of medical technology. He is the past chair of the Academy of Managed Care Pharmacy executive committee on the AMCP Format for Formulary Submissions– the United States evidence-based guidelines for formulary decision-making.
Dr. Sullivan is a member of the Medicare Evidence Development and Coverage Advisory Committee. He is also on the editorial boards of Value in Health, PharmacoEconomics, Journal of Medical Economics, European Journal of Health Economics. He is a past president of the International Society for Pharmacoeconomics and Outcomes Research and was recently awarded the Stephen G. Avey Lifetime Achievement Award from the Academy of Managed Care Pharmacy.
Craig Tall - Director
Craig Tall is the retired vice chair of corporate development for Washington Mutual, Inc. As a member of the company’s executive committee from 1990-2004, his management responsibilities at Washington Mutual involved acquisitions, its commercial banking group, its consumer finance company, its life insurance company and many corporate functions – including strategic planning, real estate, special credits and its venture capital investment arm. Before joining Washington Mutual, Craig was the president of Compensation Programs, Inc., a national employee benefits consulting firm. Craig received his bachelor’s degree in economics from the Wharton School of Finance at the University of Pennsylvania, and did graduate studies in corporate finance and marketing at the University of California, Berkeley. He is a graduate of Seattle’s Lakeside School.
Craig was a founder and past president of the Board of Trustees of the Seattle Academy of Arts and Sciences, and previously has served as president of the board of trustees of the Washington chapter of the Leukemia and Lymphoma Society of America. He is a former board member of the Pacific Northwest Ballet, the Make A Wish Foundation, the American Heart Association, the American Cancer Society and TrueBlue, Inc. (NYSE: TBI).
In addition to serving as a board member for Concure Oncology/Breast Microseed Treatment, he currently serves on the boards of Cascadia Capital Holdings, the Space Needle Corporation, Chihuly Garden and Glass, and Beat Biotherapeutics.
Kevin Kelley - Director
Kevin has had an extensive career in executive leadership, operations, finance, strategic sales, and consulting across multiple industries and platforms. Spanning from health care to medical devices to capital markets – and other intellectual property-dependent companies - Kevin has led a number of companies – as CEO and CFO - during periods of transition and growth. He has a successful track record monetizing the value of intellectual property. His nearly 30 year career includes over seven years in health care or health care-related industries.
He has served as CEO, CFO, SVP Business Development, and consultant for companies as varied as a medical device manufacturer and a green technology / patent-driven company, as well as other early stage technology companies. As a CEO and CFO, Kevin has a successful track record monetizing the value of intellectual property, negotiating strategic opportunities, and creating value.
Kevin helped lead the restructuring of ClearMedical – a company with an FDA 510k requirement for most of its devices and extremely aggressive competitive and distribution challenges. He negotiated key national purchasing agreements and then, as CFO, led a bridge and preferred round to capitalize the company’s new expansion plan.
Within two years after becoming CEO, he led the complete transformation of a company that held the rights to a revolutionary product in the industrial coatings space – in the process transformed a company with little or no value into a company with market presence and a significant valuation. He built the brand and the distribution channels, negotiated a key international strategic alliance, and established new manufacturing processes – all which eventually attracted a strategic offer from a Fortune 100 company to buy the business.
Kevin has also served as interim executive financial management for a business unit of Swedish Health Services. He was the financial interface with the health system financial team during a time of significant restructuring of the business.
Kevin began his career as a CPA at the Financial Accounting Standards Board and continued on to KPMG in Seattle as a manager in their financial services practice. After five years at KPMG he left to found an institutional fixed income portfolio advisory firm with a partner in Seattle where he specialized in mortgage backed securities and structured US Agency bonds. After eight successful years advising funds on trading strategies he left to focus on new ventures.